Synergism of benflumetol and artemether in Plasmodium falciparum.

M Hassan Alin Department of Pharmacy, Biomedical Centre, Uppsala University, Sweden.

Search for other papers by M Hassan Alin in
Current site
Google Scholar
PubMed
Close
,
A Björkman Department of Pharmacy, Biomedical Centre, Uppsala University, Sweden.

Search for other papers by A Björkman in
Current site
Google Scholar
PubMed
Close
, and
W H Wernsdorfer Department of Pharmacy, Biomedical Centre, Uppsala University, Sweden.

Search for other papers by W H Wernsdorfer in
Current site
Google Scholar
PubMed
Close
Restricted access

Using a continuous in vitro culture system, the sensitivity of Plasmodium falciparum to artemether and a new antimalarial drug, benflumetol (lumefantrine), alone and in combination, was investigated with a multiresistant strain (T-996) from Thailand and a chloroquine-resistant strain (LS-21) from India. Both strains showed similar 50% inhibitory concentration (IC50) levels with artemether alone or benflumetol alone, but the IC90 was higher in strain T-996 compared with strain LS-21: for artemether, 34.45 and 7.11 nmol/L (10.28 and 2.12 ng/ml of erythrocyte-medium mixture [EMM]), and for benflumetol, 293.03 and 95.61 nmol/L (154.69 and 50.47 ng/ml of EMM). When tested in association at artemether:benflumetol (mol: mol) ratios between 100:1 and 1:100, substantial synergism was seen in both strains, especially at the IC90 and IC99 levels. This phenomenon resembles the synergistic interaction of artemisinin derivatives and mefloquine, first observed in laboratory models and later confirmed in clinical experience.

Author Notes

 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save